Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2017
Jan. 31, 2016
Jan. 31, 2015
Cash flows from operating activities:      
Net loss $ (71,249) $ (47,697) $ (27,484)
Net income from discontinued operations     (5)
Adjustments to reconcile net loss to net cash used in continuing operating activities:      
Depreciation and amortization of property and equipment 2,953 3,380 3,683
Provision for loss contract (4,118) 9,162  
Amortization of intangible assets 3,302 4,780 5,154
Provision for bad debts 597 58 80
Stock-based compensation expense 2,621 3,552 3,220
Deferred income taxes 14,676 (985) (372)
Loss on impairment of long-lived assets 23,772 21,464  
Other non-cash reconciling items, net 1,121 139 432
Changes in operating assets and liabilities, excluding impact of acquisitions:      
Accounts receivable 42 (1,721) 3,567
Unbilled receivables 4,694 (4,359) (1,993)
Inventories 806 (937) 3,183
Prepaid expenses and other assets 1,378 (1,097) 1,570
Accounts payable (1,674) 874 (1,619)
Accrued expenses (5,055) (2,713) 1,650
Deferred revenues (2,417) (1,431) (5,699)
Other operating activities 30 (1,132) 1,289
Net cash used in operating activities from continuing operations (28,521) (18,663) (13,344)
Net cash provided by operating activities from discontinued operations     5
Total cash used in operating activities (28,521) (18,663) (13,339)
Cash flows from investing activities:      
Purchases of property and equipment (683) (1,397) (1,873)
Investment in capitalized software   (2,440)  
Purchases of marketable securities (2,008) (9,033) (9,193)
Proceeds from sale and maturity of marketable securities 4,005 11,043 7,181
Proceeds from (purchase of) cost method investments, net   464 (2,000)
Acquisition of businesses and payment of contingent consideration, net of cash acquired (5,243) (11,686)  
Advance for TLL, LLC acquisition     (2,500)
Other investing activities 30 (79) 229
Total cash used in investing activities (3,899) (13,128) (8,156)
Cash flows from financing activities:      
Proceeds from issuance of common stock 60 193  
Repurchase of our common stock     (5,504)
Total cash provided by (used in) financing activities 60 193 (5,504)
Effect of exchange rate changes on cash 1,929 312 1,284
Net decrease in cash and cash equivalents (30,431) (31,286) (25,715)
Cash and cash equivalents, beginning of period 58,733 90,019 115,734
Cash and cash equivalents, end of period 28,302 58,733 90,019
Supplemental disclosure of cash flow information:      
Income taxes paid 178 640 671
Interest paid 6 6 6
Supplemental disclosure of non-cash investing and financing activities:      
Transfer of items originally classified as inventories to equipment 24 532 $ 474
DCC Labs [Member]      
Supplemental disclosure of non-cash investing and financing activities:      
Fair value of common stock issued for acquisition 2,640    
Timeline Labs [Member]      
Adjustments to reconcile net loss to net cash used in continuing operating activities:      
Loss on impairment of long-lived assets   21,900  
Supplemental disclosure of non-cash investing and financing activities:      
Fair value of common stock issued for acquisition   3,019  
Common Stock [Member]      
Supplemental disclosure of non-cash investing and financing activities:      
Fair value of common stock issued for deferred stock consideration obligation $ 3,452 $ 1,754